» Articles » PMID: 6110604

Acute Effects of Alloxan- and Streptozotocin-induced Insulin Deficiency on Somatostatin and Glucagon Secretion by the Perfused Isolated Rat Pancreatico-duodenal Preparation

Overview
Journal Diabetologia
Specialty Endocrinology
Date 1981 Jan 1
PMID 6110604
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The secretion of somatostatin and glucagon by the perfused rat pancreatico-duodenal preparation was examined in situ under control conditions and after the induction of acute insulin deficiency by alloxan or streptozotocin. A 10 min 0.625 mmol/l alloxan perfusion resulted in an immediate and transient increase in basal insulin and glucagon release and a slightly delayed and persistent increase in basal somatostatin secretion. The insulin responses to 16.7 mmol/l glucose, 1 mmol/l theophylline, and 19 mmol/l arginine alone or in combination were virtually eliminated by alloxan treatment. Somatostatin secretion in response to the stimuli was completely inhibited or markedly attenuated. The glucagon-suppressive effect of glucose was unaltered by alloxan and the stimulatory effect of arginine was enhanced. Addition of 1 microgram/ml porcine insulin to the perfusion medium did not modify the alterations in somatostatin and glucagon responses to arginine. Streptozotocin treatment 90 min prior to the onset of perfusion resulted in changes in somatostatin, glucagon, and insulin responses to glucose and arginine similar to those of alloxan. The present results are consistent with an effect of alloxan and streptozotocin on the D cell similar to that on the B cells, namely, interference with a glucose-mediated effect on hormone secretion.

Citing Articles

Modulation by glucose and D-glyceraldehyde of glucagon and insulin secretion in the isolated perfused streptozotocin-treated rat pancreas.

Goto Y, Seino Y, NOTE S, Imura H Acta Diabetol Lat. 1982; 19(1):23-8.

PMID: 7041500 DOI: 10.1007/BF02581182.


Pentamidine, a new diabetogenic drug in laboratory rodents.

Sai P, Boillot D, Boitard C, DEBRAY-SACHS M, Reach G, Assan R Diabetologia. 1983; 25(5):418-23.

PMID: 6360780 DOI: 10.1007/BF00282521.


Role of glucose and insulin in the dynamic regulation of glucagon release by the perfused rat pancreas.

Marchand J, Malaisse W Diabetologia. 1983; 24(3):191-5.

PMID: 6341147 DOI: 10.1007/BF00250160.


Loss of a priming effect of glucose on A and D cell secretion in perfused pancreases from alloxan-diabetic rats: role of insulin and alloxan.

Grill V, Efendic S Diabetologia. 1983; 24(1):47-51.

PMID: 6131006 DOI: 10.1007/BF00275947.


Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect.

Ostenson C, Nylen A, Grill V, Gutniak M, Efendic S Diabetologia. 1986; 29(12):861-7.

PMID: 3106122 DOI: 10.1007/BF00870141.

References
1.
Schusdziarra V, Dobbs R, Harris V, Unger R . Immunoreactive somatostatin levels in plasma of normal and alloxan diabetic dogs. FEBS Lett. 1977; 81(1):69-72. DOI: 10.1016/0014-5793(77)80930-7. View

2.
Goto Y, Seino Y, Taminato T, Inoue Y, Kadowaki S, Mori K . Modulation by alloxan of glucagon and insulin secretion in the isolated perfused rat pancreas. Endocrinology. 1978; 102(5):1496-500. DOI: 10.1210/endo-102-5-1496. View

3.
Rufener C, Amherdt , Dubois M, Orci L . Letter: Ultrastructural immunocytochemical localization of somatostatin in rat pancreatic monolayer culture. J Histochem Cytochem. 1975; 23(11):866-9. DOI: 10.1177/23.11.1194672. View

4.
Hermansen K . The role of sodium in somatostatin secretion: evidence for the involvement of Na+ channels in the release mechanism. Endocrinology. 1980; 106(6):1843-7. DOI: 10.1210/endo-106-6-1843. View

5.
PAGLIARA A, Stillings S, Zawalich W, Williams A, Matchinsky F . Glucose and 3-O-methylglucose protection against alloxan poisoning of pancreatic alpha and beta cells. Diabetes. 1977; 26(10):973-9. DOI: 10.2337/diab.26.10.973. View